Natalia Ruetalo
Overview
Explore the profile of Natalia Ruetalo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
650
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu A, Salker M, Ruetalo N, Raja Xavier J, Raja Xavier J, Lankapalli A, et al.
Clin Sci (Lond)
. 2024 Dec;
139(4).
PMID: 39666439
Vertical transmission of SARS-CoV-2 during human pregnancy remains highly controversial as most studies have focused on the third trimester or the peripartum period. Given the lack of early trimester data,...
2.
Tandler C, Heitmann J, Michel T, Marconato M, Jaeger S, Tegeler C, et al.
Int J Infect Dis
. 2023 Nov;
139:69-77.
PMID: 38016500
Objectives: T cell immunity is key for the control of viral infections including SARS-CoV-2, in particular with regard to immune memory and protection against arising genetic variants. Methods: We recently...
3.
Compounds derived from Humulus lupulus inhibit SARS-CoV-2 papain-like protease and virus replication
Herzog A, Gobel K, Marongiu L, Ruetalo N, Campos Alonso M, Leischner C, et al.
Phytomedicine
. 2023 Nov;
123:155176.
PMID: 37976697
Background: Selected natural compounds exhibit very good antiviral properties. Especially, the medicinal plant Humulus lupulus (hop) contains several secondary plant metabolites some of which have previously shown antiviral activities. Among...
4.
Zekri L, Ruetalo N, Christie M, Walker C, Manz T, Rammensee H, et al.
Front Immunol
. 2023 Mar;
14:1112505.
PMID: 36969164
Despite the successful development of vaccines and neutralizing antibodies to limit the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerging variants prolong the pandemic and emphasize the persistent...
5.
Ruetalo N, Berger S, Niessner J, Schindler M
Indoor Air
. 2022 Sep;
32(9):e13115.
PMID: 36168221
Surface residing SARS-CoV-2 is efficiently inactivated by UV-C irradiation. This raises the question whether UV-C-based technologies are also suitable to decontaminate SARS-CoV-2- containing aerosols and which doses are needed to...
6.
Sinnberg T, Lichtensteiger C, Ali O, Pop O, Jochum A, Risch L, et al.
Am J Respir Crit Care Med
. 2022 Aug;
207(1):38-49.
PMID: 35926164
Coronavirus disease 2019 (COVID-19) can lead to acute respiratory distress syndrome with fatal outcomes. Evidence suggests that dysregulated immune responses, including autoimmunity, are key pathogenic factors. To assess whether IgA...
7.
Junker D, Dulovic A, Becker M, Wagner T, Kaiser P, Traenkle B, et al.
Sci Rep
. 2022 May;
12(1):7168.
PMID: 35505068
As global vaccination campaigns against SARS-CoV-2 proceed, there is particular interest in the longevity of immune protection, especially with regard to increasingly infectious virus variants. Neutralizing antibodies (Nabs) targeting the...
8.
Ruetalo N, Flehmig B, Schindler M, Pridzun L, Haage A, Reichenbacher M, et al.
Viruses
. 2021 Dec;
13(12).
PMID: 34960605
The new WHO reference standard allows for the definition of serum antibodies against various SARS-CoV-2 antigens in terms of binding antibody units (BAU/mL) and thus to compare the results of...
9.
Froba M, Grosse M, Setz C, Rauch P, Auth J, Spanaus L, et al.
Int J Mol Sci
. 2021 Dec;
22(24).
PMID: 34947999
The COVID-19 pandemic continues to spread around the world and remains a major public health threat. Vaccine inefficiency, vaccination breakthroughs and lack of supply, especially in developing countries, as well...
10.
Wagner T, Schnepf D, Beer J, Ruetalo N, Klingel K, Kaiser P, et al.
EMBO Rep
. 2021 Dec;
23(2):e53865.
PMID: 34927793
The ongoing COVID-19 pandemic and the emergence of new SARS-CoV-2 variants of concern (VOCs) requires continued development of effective therapeutics. Recently, we identified high-affinity neutralizing nanobodies (Nbs) specific for the...